Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 64

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 64
---
 and China.                                                  |

Pursuant to the Yissum License Agreements, we have an exclusive, worldwide license for the development, use, manufacture and commercialization of products arising out of patents owned by, and patent applications filed by, Yissum in connection with the H19 gene. All of patents and patent applications listed below were licensed to us by Yissum pursuant to the Yissum License Agreements.

| Status  
 Granted 
 Granted 
 Granted |     | Country 
 US      
 EP      
 EP-BE   |     | Application Date 
 October 10, 2016 
 October 11, 2016 
 October 11, 2016 |     | Publication Number 
       2017/0027869 
            3142642 
            3142642 |     | Patent Date       
 June 26, 2018     
 August 29, 2018   
 August 29, 2018   |     |                Patent Number 
                   10,004,688 
                      3142642 
                      3142642 |     | Expiry Date   
 April 8, 2035 
 April 8, 2035 
 April 8, 2035 |
|:--------|:----|:--------|:----|:-----------------|:----|-------------------:|:----|:------------------|:----|-----------------------------:|:----|:--------------|
| Granted |     | EP-DK   |     | October 11, 2016 |     |            3142642 |     | August 29, 2018   |     |                      3142642 |     | April 8, 2035 |
| Granted |     | EP-FR   |     | October 11, 2016 |     |            3142642 |     | August 29, 2018   |     |                      3142642 |     | April 8, 2035 |
| Granted |     | EP-DE   |     | October 11, 2016 |     |            3142642 |     | August 29, 2018   |     |   6020150155610 (EP 3142642) |     | April 8, 2035 |
| Granted |     | EP-IE   |     | October 11, 2016 |     |            3142642 |     | August 29, 2018   |